American Association for the Advancement of Science, Science Translational Medicine, 536(12), 2020
DOI: 10.1126/scitranslmed.aay0271
Full text: Unavailable
Genome-wide CRISPR-Cas9 screens identify druggable pathways associated with facioscapulohumeral muscular dystrophy.